We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+12.98%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$52.8B
AUM Growth
+$12.4B
(+31%)
Cap. Flow
+$6.6B
Cap. Flow
% of AUM
12.49%
Top 10 Holdings %
Top 10 Hldgs %
10.83%
Holding
4,679
New
953
Increased
1,510
Reduced
1,399
Closed
740
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$763M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$336M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$246M |
| 4 |
Apple
AAPL
|
+$203M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuit
INTU
|
+$158M |
| 2 |
Sherwin-Williams
SHW
|
+$155M |
| 3 |
Goldman Sachs
GS
|
+$139M |
| 4 |
Bank of America
BAC
|
+$127M |
| 5 |
Royal Caribbean
RCL
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.3% |
| 2 | Consumer Discretionary | 7.9% |
| 3 | Healthcare | 4.86% |
| 4 | Financials | 4.75% |
| 5 | Industrials | 3.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NGM
3626
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $183K | ﹤0.01% |
212,916
+73,257
| +52% | +$64.3K |
|
3627
Westwood Holdings Group
WHG
$182M
| $182K | ﹤0.01% |
+14,493
| New | +$153K |
|
3628
PUT
Barclays
BCS
$94.1B
| $182K | ﹤0.01% |
23,100
| – | – |
|
|
GBIO
3629
DELISTED
Generation Bio
GBIO
| $182K | ﹤0.01% |
11,023
+5,572
| +102% | +$97.2K |
|
|
PTVE
3630
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $181K | ﹤0.01% |
13,199
-11,172
| -46% | -$118K |
|
3631
Spero Therapeutics
SPRO
$68.9M
| $181K | ﹤0.01% |
122,802
-6,695
| -5% | -$7.98K |
|
3632
Algonquin Power & Utilities
AQN
$4.69B
| $178K | ﹤0.01% |
28,241
-126,878
| -82% | -$741K |
|
3633
Heartland Express
HTLD
$1.11B
| $178K | ﹤0.01% |
12,516
-2,035
| -14% | -$27.8K |
|
3634
The Joint Corp
JYNT
$119M
| $178K | ﹤0.01% |
18,506
-32,689
| -64% | -$283K |
|
3635
CALL
Baytex Energy
BTE
$3.08B
| $177K | ﹤0.01% |
+53,300
| New | +$206K |
|
|
KZR
3636
DELISTED
Kezar Life Sciences
KZR
| $177K | ﹤0.01% |
18,671
+3,378
| +22% | +$29.7K |
|
|
VIA
3637
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $177K | ﹤0.01% |
18,800
-7,343
| -28% | -$57.7K |
|
3638
Suzano
SUZ
$10.2B
| $177K | ﹤0.01% |
+15,552
| New | +$168K |
|
3639
P3 Health Partners
PIII
$32M
| $176K | ﹤0.01% |
2,501
+1,875
| +300% | +$129K |
|
|
SILK
3640
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $176K | ﹤0.01% |
14,367
-14,184
| -50% | -$133K |
|
|
BLDP
3641
Ballard Power Systems
BLDP
$874M
| $176K | ﹤0.01% |
47,477
+27,880
| +142% | +$99.1K |
|
|
TE
3642
T1 Energy
TE
$1.4B
| $176K | ﹤0.01% |
+93,916
| New | +$253K |
|
3643
Clover Health Investments
CLOV
$2.28B
| $175K | ﹤0.01% |
183,493
+156,084
| +569% | +$153K |
|
3644
Funko
FNKO
$323M
| $175K | ﹤0.01% |
+22,582
| New | +$163K |
|
3645
Bain Capital Specialty
BCSF
$802M
| $173K | ﹤0.01% |
+11,485
| New | +$175K |
|
|
MAPS
3646
DELISTED
WM TECHNOLOGY INC A
MAPS
| $172K | ﹤0.01% |
+238,875
| New | +$237K |
|
3647
B&G Foods
BGS
$285M
| $171K | ﹤0.01% |
+16,265
| New | +$151K |
|
3648
CALL
Clean Energy Fuels
CLNE
$447M
| $170K | ﹤0.01% |
44,400
| – | – |
|
3649
CALL
RLX Technology
RLX
$2.48B
| $170K | ﹤0.01% |
+85,000
| New | +$158K |
|
3650
NCR Voyix
VYX
$1.06B
| $169K | ﹤0.01% |
+10,000
| New | +$160K |
|
Similar funds
Squarepoint's Q4 2023 Portfolio in Review
As of Q4 2023, Squarepoint held 4,679 positions worth $52.8B, up 31% from $40.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Squarepoint deployed $6.6B of net new capital in Q4 2023, opening 953 new positions and adding to 1,510 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 550,000 shares worth $263M.
By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Intuit, an estimated $158M trimmed.
- Squarepoint's largest Q4 2023 buy was iShares Core S&P 500 ETF: 550,000 shares worth $263M.
- Squarepoint added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $763M increase.
- Squarepoint's biggest Q4 2023 reduction was Intuit, cutting an estimated $158M.
- Squarepoint fully exited State Street SPDR S&P MIDCAP 400 ETF Trust in Q4 2023, selling an estimated $97.9M.
- Squarepoint's ten largest holdings make up 11% of its $52.8B portfolio in Q4 2023.
- Squarepoint opened 953 new positions and closed 740 in Q4 2023.
- Squarepoint's portfolio value rose 31% quarter-over-quarter to $52.8B.
Based on Squarepoint's 13F filing for Q4 2023, filed 14 Feb 2024.